Ipsen provides update on Phase III BOLD trial in biliary atresia

PARIS, FRANCE, 24 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III BOLD trial evaluating ...

NVCR Stock Surges 28% For Best Day In Over 1.5 Years — What’s Driving The Rally?

The medical device maker, which develops Tumor Treating Fields (TTFields) therapy for cancer, said Q2 marked its strongest ...

Omnissa Named a Leader in Endpoint Management Platforms by Independent Research Firm

Omnissa®, a leading AI-driven digital work platform company, today announced it has been named a Leader in The Forrester Wave™: Endpoint Management Platforms, Q2 2026. The company received the highest ...